BioNano Genomics Inc (NASDAQ:BNGO) shares are trading higher by 19.5% at $7.36 Monday on continued strength following last week’s publication of DNA replication data, a fundamental process of cell growth implicated in cancer that was previously hard to study in human genomes. 

Bionano Genomics is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

See also: How to Buy Bionano Genomics Inc. (BNGO) Stock